|
Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell …
MarketWatch (press release) Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO. MEL200 demonstrated a longer median PFS and OS compared … ASCO 2013 Multiple Myeloma Update – Day Two: Education SessionThe Myeloma Beacon |
Israeli child's donated kidney saves Palestinian boy – Israel Today
|
Israeli child’s donated kidney saves Palestinian boy
Israel Today … the Times of Israel. Naom’s father told Israel’s News1 that for he and his wife, it made no difference that the recipient of their son’s kidney was a Palestinian Arab. PHOTO: 3-year-old Noam Naor, who tragically suffered brain death after falling … |
Blood donation opportunities with American Red Cross – fox6now.com
|
Blood donation opportunities with American Red Cross
fox6now.com MILWAUKEE (WITI) — The American Red Cross encourages eligible donors to give blood this summer, helping to ensure a sufficient supply for patients in need and allowing them to create their summer of stories. Below are just a few examples of patients … Red Cross explains blood donation processStanly News & Press Red Cross Blood Drive Becoming New RiverFest TraditionKAKE |
TG Therapeutics, Inc. Announces Presentation of Interim Results From Its Phase … – NASDAQ (press release)
|
TG Therapeutics, Inc. Announces Presentation of Interim Results From Its Phase …
NASDAQ (press release) NEW YORK, June 3, 2013 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. ( TGTX ) today announced preliminary results from a Phase 1 clinical study of single-agent ublituximab (TG-1101) in patients with rituximab relapsed and/or refractory Non-Hodgkin’s … |
TG Therapeutics , Inc . Announces Presentation of Interim Results From Its … – MarketWatch
|
TG Therapeutics , Inc . Announces Presentation of Interim Results From Its …
MarketWatch TG Therapeutics, Inc. (TGTX) today announced preliminary results from a Phase 1 clinical study of single-agent ublituximab (TG-1101) in patients with rituximab relapsed and/or refractory Non-Hodgkin’s Lymphoma (NHL), presented at the American Society … |
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for … – 7thSpace Interactive (press release)
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for …7thSpace Interactive (press release)We further hypothesized that treatment with cyclosporine A, a Pgp1 inhibitor, would render cells more sensitive to treatment with corticost…
INTERNATIONAL > Human rights body calls on int'l sister bodies for … – Hurriyet Daily News
|
INTERNATIONAL > Human rights body calls on int’l sister bodies for …
Hurriyet Daily News When asked whether he was in a position to confirm these reports, Bakkalcı referred to the written statement by the TİHV which said, “There are extremely persuasive and strong claims about brain death of a young person of ours in Ankara as of last … |
Scientists develop new method for finding therapeutic antibodies – domain-B
Scientists develop new method for finding therapeutic antibodiesdomain-BScientists at The Scripps Research Institute (TSRI) at La Jolla, California, have devised a powerful new technique for finding antibodies that have a desired biological effect. Ant…
Uganda: New Hope for Heart Patients – AllAfrica.com
Uganda: New Hope for Heart PatientsAllAfrica.comSeven-year-old Joshua Mukalazi is a heart patient and very lucky to be the second beneficiary of Keith Heart Foundation (KHF). He received sponsorship for treatment in India for the second time after Mula…
Compensation sum insulting to acid attack victim in Mumbai: Sushma Swaraj – Times of India
Compensation sum insulting to acid attack victim in Mumbai: Sushma SwarajTimes of IndiaShe suffered grievous injuries which included collapse of her right lung, damage to her left lung, oesophagus, windpipe, trachea and other vital organs. Preeti succu…